Iganidipine is an antagonist of Ca2+ .

In monkeys, Iganidipine( 0.03% and 0.1% solution) obviously enhances NBONH in treated eyes by 20 and 41% after 7-day (p<0.05) twice-daily administration, respectively. Iganidipine (0.03% solution) obviously enhances optic nerve head (ONH) tissue blood velocity (NBONH) by 8 to 10% in treated eyes after a single administration (p<0.05) or by 18 to 35% after 7-, 14-, or 21-day twice-daily administration in rabbits (p<0.05) [1].

119687-33-1

C28H38N4O6

526.62

Iganidipine

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years